Literature DB >> 830579

Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.

J L Shurberg, R H Resnick, R S Koff, E Ros, R A Baum, J A Pallotta.   

Abstract

The cholesterol-lowering effect of portacaval anastomosis in homozygous familial hypercholesterolemia suggested a study of lipid metabolism in cirrhotic patients after portasystemic anastomoses. Fasting serum cholesterol, triglycerides, insulin, and glucagon levels were obtained in 20 patients with alcoholic cirrhosis and portacaval anastomosis, and in 21 nonshunted subjects with cirrhosis. After 100 g of glucose, given orally, insulin and glucagon levels were measured. In the shunted patients serum cholesterol was higher than in the nonshunted subjects, 240 +/- 15 mg per 100 ml (mean +/- 1 SEM) versus 180 +/- 13 mg per 100 ml, P less than 0.01. Triglycerides were normal in both groups. Fasting insulin was elevated to a greater extent in the shunted patients with cirrhosis (36 +/- 5 muU per ml) than in the nonshunted patients (22 +/- 4 muU per ml), P less than 0.05. Two hours after glucose, insulin levels were also elevated to a greater extent in the shunted subjects (304 +/- 50 muU per ml) than in the nonshunted subjects (167 +/- 29 muU per ml), P less than 0.03. Fasting glucagon (corrected for interference factor) was elevated to a greater extent in the shunted subjects (204 +/- 35 pg per ml) than in the nonshunted subjects (80 +/- 19 pg per ml), P less than 0.01. The explanation for serum cholesterol elevation after surgical shunting in cirrhotics is unknown. Two possible hypotheses--the differential action of insulin and glucagon on cholesterol metabolism and the effects of shunting on the cirrhotic liver--are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 830579

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

1.  Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis.

Authors:  A V Greco; F Crucitti; G Ghirlanda; R Manna; L Altomonte; A G Rebuzzi; A Bertoli
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

2.  Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis.

Authors:  A V Greco; L Altomonte; G Ghirlanda; A G Rebuzzi; R Manna; A Bertoli
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

3.  The presence of glucagon in ascitic fluid in cirrhotic patients.

Authors:  U M Kabadi; M S Uddinn; A B Eisenstein
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

4.  The effect of portacaval shunt upon hepatic cholesterol synthesis and cyclic AMP in dogs and baboons.

Authors:  A Francavilla; A F Jones; J Benichou; T E Starzl
Journal:  J Surg Res       Date:  1980-01       Impact factor: 2.192

5.  Effect of somatostatin (SRIF) on plasma glucose and insulin response to glucagon in liver cirrhosis.

Authors:  L Altomonte; A V Greco; G Ghirlanda; A G Rebuzzi; R Manna; A Bertoli
Journal:  Acta Diabetol Lat       Date:  1979 Apr-Jun

6.  Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.

Authors:  L Gerö; L Korányi; F Szalay; B Büki; G Tamás
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar

7.  Portacaval shunt in patients with familial hypercholesterolemia.

Authors:  T E Starzl; H P Chase; E H Ahrens; D J McNamara; D W Bilheimer; E J Schaefer; J Rey; K A Porter; E Stein; A Francavilla; L N Benson
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

8.  Ammonium urate urolithiasis in the rat with portocaval shunt--some aspects of mineral metabolism and urine composition.

Authors:  U Linnemann; P Kuch; P O Schwille
Journal:  Urol Res       Date:  1986

9.  Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis.

Authors:  T Kasperska-Czyźykowa; L G Heding; A Czyzyk
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

10.  Plasma pancreatic glucagon in pancreatic and primary diabetes, and liver cirrhosis: application of a correction to the radioimmunoassay for pancreatic glucagon.

Authors:  N Okumura; T Hayakawa; K Yasui; A Noda; T Kondo; K Otsuka; Y Nimura
Journal:  Gastroenterol Jpn       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.